Αποτελέσματα Αναζήτησης
Download PDF Guideline Development Process ... Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K. (2019) Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache ...
This handout provides information for children with migraine headaches, ages 6-17 years old. Any child with headache, at any age, should a healthcare provider. DISCLAIMER: The recommendations and all other information in this resource are based on published guidelines and expert consensus by the Pediatric Canadian Headache Network (PeCaHN).
This guideline, for use by primary care providers, explains the evaluation, treatment, and referral process for children and adolescents (ages 3-21 years) whose chief complaint is headache.
The International Classification of Headache Disorders gives useful descriptions and diagnostic criteria that are especially useful for primary headaches. The National Institute for Health and Care Excellence (NICE) Clinical Guideline 150 provides evidence-based recommendations on treatments for adults and young people from age 12 years.
INTRODUCTION. Although this article will focus on the drug therapy of primary headaches, it is vital that prescribers understand how to differentiate primary from secondary headaches and also the varieties of primary headache that will present in childhood.
migraine treatments in children and adolescents. The guide-line seeks to answer the following clinical question: In children and adolescents with migraine, do acute self-administered treatments, compared with placebo, reduce headache pain and associated symptoms (nausea, vomiting, photophobia, and phonophobia) and maintain headache freedom?
New onset headaches: follow-up in 2 to 4 weeks. Children with high frequency headaches (>8 headaches per month) and new changes to treatment plan: follow-up in 4 to 6 weeks. Children with low frequency headaches (<8 headaches per month) and new changes to treatment plan: follow-up in 8 to 12 weeks.
